Page 7 of 14 – SEC Filing CUSIP No. 87184Q107 13G Page 7 of 11
1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) James E. Flynn 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) ý 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 2,095,220 (4) 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 2,095,220 (4) 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,095,220 (4) 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* o 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.97% 12. TYPE OF REPORTING PERSON* IN
__________________ (4) Comprised of Common Stock held by Deerfield Private Design Fund III, L.P. and Deerfield Special Situations Fund, L.P. Follow Syros Pharmaceuticals Inc.
Follow Syros Pharmaceuticals Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| CUSIP No. | 87184Q107 | 13G | Page 7 of 11 |
| 1. | NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) James E. Flynn | ||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* | (a) o (b) ý | |
| 3. | SEC USE ONLY | ||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION United States | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 | |
| 6. | SHARED VOTING POWER 2,095,220 (4) | ||
| 7. | SOLE DISPOSITIVE POWER 0 | ||
| 8. | SHARED DISPOSITIVE POWER 2,095,220 (4) | ||
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,095,220 (4) | ||
| 10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* | o | |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.97% | ||
| 12. | TYPE OF REPORTING PERSON* IN | ||
__________________
(4) Comprised of Common Stock held by Deerfield Private Design Fund III, L.P. and Deerfield Special Situations Fund, L.P.
Follow Syros Pharmaceuticals Inc.
Follow Syros Pharmaceuticals Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.